Skip to main content
SpringerLink
Log in

Islet amyloid polypeptide (amylin) increases the renal excretion of calcium in the conscious dog

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Islet amyloid polypeptide (IAPP) is a member of the calcitonin/CGRP family and has been isolated from the β-cell of pancreatic islets. Recent evidence suggests that this peptide may be involved in calcium metabolism in that its administration resulted in lowering of serum calcium levels. To determine the mechanism of IAPP-induced hypocalcemia, the peptide was infused at 50 pmol/min/kg for 90 minutes in conscious male mongrel dogs. Infusion of the peptide resulted in a modest decline in the total serum calcium concentration (10.4±0.2 to 9.4±0.2 mg/dl; P<0.05) and a concomitant increase in urinary calcium excretion (3.6±0.6 to 6.9±2.0 mg/dl; P<0.01). Based on an extracellular volume of 7 liter in a 28 kg dog, the total decrement in calcium due to IAPP was 41.3±2.4 mg, whereas the total increase in urinary calcium was 3.2±0.7 mg. There were no detectable changes in calcitonin. We conclude that IAPP lowers serum calcium and increases the renal excretion of calcium independently of calcitonin. However, the calciuria can only account for a small component of the hypocalcemic effect and therefore, an additional calcium lowering effect of IAPP exits.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

references

  1. Cooper GJS, Willis AC, Clark A, Turner RC, Sims RB, Reid KBM (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628–8632

    Google Scholar 

  2. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84:3881–3885

    Google Scholar 

  3. Johnson KH, O'Brien TD, Hayden DW, Jordan K, Ghobrial HKG, Mahoney WC, Westermark P (1988) Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Pathol 130:1–8

    Google Scholar 

  4. Lukinius A, Wilander E, Westermark GT, Engstrom U, Westermark P (1989) Colocalization of islet amyloid polypeptide and insulin in the β-cell secretory granules of the human pancreatic islets. Diabetologia 32:240–244

    Google Scholar 

  5. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH (1987) Islet amyloid in type 2 human diabetic mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127:414–417

    Google Scholar 

  6. Nishi N, Sanke T, Nagamatsu S, Bell GI, Steiner DF (1990) Islet-amyloid polypeptide: a new β-cell secretory product related to islet amyloid deposits. J Biol Chem 265:4173–4176

    Google Scholar 

  7. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue specific RNA processing. Nature 304:129–135

    Google Scholar 

  8. Roberts AN, Leighton B, Todd JA, Cockburn D, Schofield PN, Sutton R, Holt S, Boyd Y, Day AJ, Foot EA (1989) Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. Proc Natl Acad Sci USA 86:9662–9666

    Google Scholar 

  9. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ, Porte D, Jr. (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes 39:634–638

    Google Scholar 

  10. Mitsukawa T, Takemura J, Asai J, Nakazato M, Kangawa K, Matsuo H, Matsukura S (1990) Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes 39:639–642

    Google Scholar 

  11. Hartter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E, Brunnbaer M, Woloszczuk W, Prager R (1991) Basal and stimulated plasma levels of pancreatic amylin indicate its cosecretion with insulin in humans. Diabetologia 34:52–54

    Google Scholar 

  12. Butler PC, Chou J, Carter WB, Wang Y-N, Bu B-H, Chang D, Chang J-K, Rizza RA (1990) Effect of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39:752–756

    Google Scholar 

  13. Van Jaarsveld BC, Hackeng WHL, Nieuwenhuis MG, Erkelens DW, Geerdink RA, Lips CJM (1990) Islets-amyloid polypeptide in human plasma (Letter). Lancet 335:60

    Google Scholar 

  14. Nakazato M, Asai J, Kangawa K, Matsukura S, Matsuo H (1989) Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentration. Biochem Biophys Res Commun 164:394–399

    Google Scholar 

  15. Sanke T, Bell GI, Sample C, Rubenstein AH, Steiner DF (1988) An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing. J Biol Chem 263:17243–17246

    Google Scholar 

  16. Betsholtz C, Christmanson L, Engstrom U, Rorsman R, Jordan K, O'Brien TD, Murtaugh M, Johnson KH, Westermark P (1990) Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes 39:118–122

    Google Scholar 

  17. Mosselman S, Hoppener JWM, Zandberg J, Van Mansfeld ADM, Geurts van Kessel AHM, Lips CJM, Jansz HS (1988) Islet amyloid polypeptide: identification and chromosomal localization of the human gene. FEBS Lett 239:227–232

    Google Scholar 

  18. Leffert JD, Newgard CB, Okamoto H, Milburn JL, Luskey KL (1989) Rat amylin: cloning and tissue-specific expression in pancreatic islets. Proc Natl Acad Sci USA 86:3127–3130

    Google Scholar 

  19. Clark A, Cooper GJS, Lewis CE, Morris JF, Willis AC, Reid KBM, Turner RC (1987) Islet amyloid formed from diabetic-associated peptide may be pathogenic in type 2 diabetes. Lancet 2:231–234

    Google Scholar 

  20. Cooper GJS, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuk JM, Howland K, Rothbard JB, Willis AC, Reid KBM (1988) Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci USA 85: 7763–7766

    Google Scholar 

  21. Leighton B, Cooper GJS (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335:632–635

    Google Scholar 

  22. Molina JM, Cooper GJS, Leighton B, Olefsky JM (1990) Induction of insulin resistance in vivo by amylin and calcitonin generelated peptide. Diabetes 39:260–265

    Google Scholar 

  23. Ghatei MA, Datta HK, Zaidi M, Bretherton-Watt D, Wimalawansa SJ, MacIntyre I, Bloom SR (1989) Amylin and amylinamide lack acute effect on plasma glucose and insulin. Endocrinology 124:R9-R11

    Google Scholar 

  24. Kassir AA, Upadhyay AK, Lim TJ, Moossa AR, Olefsky JM (1991) Lack of effect of islet amyloid polypeptide in causing insulin resistance in conscious dogs during euglycemic clamp studies. Diabetes 40:998–1004

    Google Scholar 

  25. Zaidi M, Datta HK, Bevis PJR, Wimalawansa SJ, MacIntyre I (1990) Amylin-amide: a new bone-conserving peptide from the pancreas. Exp Physiol 75:529–536

    Google Scholar 

  26. Datta HK, Zaidi M, Wimalawansa SJ, Ghatei MA, Beacham JL, Bloom SR, MacIntyre I (1989) In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit. Biochem Biophys Res Commun 162:876–881

    Google Scholar 

  27. Gilbey SG, Ghatei MA, Bretherton-Watt D, Zaidi M, Jones PM, Perera T, Beacham JL, Girgis S, Bloom SR (1991) islet amyloid polypeptide: production by an osteoblast cell line and possible role as a paracrine regulator of osteoclast function in man. Clin Sci 81:803–808

    Google Scholar 

  28. Muse KN, Manolagas SC, Deftos LJ, Alexander N, Yen SSC (1986) Calcium-regulating hormones across the menstrual cycle. J Clin Endocrinol Metab 62:1313–1316

    Google Scholar 

  29. Shappell NW, Herbein JH, Deftos LJ, Aiello RJ (1987) Effects of dietary calcuim and age on parathyroid hormone, calcitonin, and serum and milk minerals in the periparturient diary cow. J Nutr 117:201–207

    Google Scholar 

  30. Catherwood BD, Deftos LJ (1987) General principles, problems, and interpretation in the radioimmunoassay of calcitonin and parathyroid hormone. In: Bikle DD (ed) Assay of calciumregulating hormones. Springer-Verlag, New York, pp 151–168

    Google Scholar 

  31. Deftos LJ, Glowacki J (1984) Mechanisms of bone metabolism. In: Kern DC, Frohlich E (eds) Pathophysiology. JB Lippincott Co, Philadelphia, PA, pp 445–468

    Google Scholar 

  32. Raisz LG (1983) Bone metabolism and its hormonal regulation. Triangle 22:81–92

    Google Scholar 

  33. Deftos LJ (1987) Calcitonin secretion in humans. In: Cooper CW (ed) Current research on calcium regulating hormones. University of Texas Press, Austin, TX, pp 79–100

    Google Scholar 

  34. Zaidi M, Breimer LH, MacIntyre I (1987) The biology of peptides from the calcitonin genes. Quart J Exp Physiol 72:371–408

    Google Scholar 

  35. Breimer LH, MacIntyre I, Zaidi M (1988) Peptides from the calcitonin genes: molecular genetics, structure and function. Biochem J 255:377–390

    Google Scholar 

  36. Zaidi M, Chambers TJ, Bevis PJR, Beacham JL, Gaines Das RE, MacIntyre I (1988) Effects of peptides from the calcitonin genes on bone and cells. Q J Exp Physiol 73:471–485

    Google Scholar 

  37. Zaidi M, Fuller K, Bevis PJR, Gaines Das RE, Chambers TJ, MacIntyre I (1987) Calcitonin gene-related peptide inhibits osteoclastic bone resorption: a comparative study. Calcif Tissue Int 40:149–154

    Google Scholar 

  38. Zaidi M, Chambers TJ, Gaines Das RE, Morris HR, MacIntyre I (1987) A direct action of human calcitonin gene-related peptide on isolated osteoclasts. Endocrinology 115:511–518

    Google Scholar 

  39. Kaiser ET, Kezdy FJ (1984) Amphiphilic secondary structure: design of peptide hormones. Science 223:249–255

    Google Scholar 

  40. Mayer GP, Hurst JG (1978) Sigmoidal relationship between parathyroid hormone secretion rate and plasma calcium concentration in calves. Endocrinology 102:1036–1042

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery (8400), University of California, San Diego Medical Center, 200 West Arbor Dr., 92103-8400, San Diego, California, USA

    P. D. G. Miles & A. R. Moossa

  2. Division of Endocrinology and Metabolism, The San Diego VA Medical Center, 92093, La Jolla, California, USA

    L. J. Deftos & J. M. Olefsky

  3. Department of Medicine, University of California, San Diego, 92093, La Jolla, California, USA

    J. M. Olefsky

Authors
  1. P. D. G. Miles
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. J. Deftos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. R. Moossa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. M. Olefsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miles, P.D.G., Deftos, L.J., Moossa, A.R. et al. Islet amyloid polypeptide (amylin) increases the renal excretion of calcium in the conscious dog. Calcif Tissue Int 55, 269–273 (1994). https://doi.org/10.1007/BF00310405

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00310405

Key words

Search

Navigation